Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging

NCT01572025 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Infertility
Ovarian Aging
Diminished Ovarian Reserve (DOR)
Predicted Poor-responders

Interventions

DRUG: Dehydroepiandrosterone
DRUG: Placebo

Sponsor

University of Nottingham